Publications Database

Barthélémy C. et al. (1981)

Behavioral and biological effects of oral magnesium, vitamin B6, and combined magnesium-B6 administration in autistic children.

Magnesium Bulletin

2 pp. 150-153

LeLord G. et al. (1981)

Effects of pyridoxine and magnesium on autistic symptoms-initial observations.

Journal of Autism and Developmental Disorders

11(2), pp. 219-230

Read Abstract (New Window)

Martineau J. et al. (1998)

Brief report: An open middle-term study of combined vitamin B6-Magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.

Journal of Autism and Developmental Disorders

18(3), pp. 435-447

Martineau J. , Garreau B. , Barthélémy C. (1981)

Effects of vitamin B6 on averaged evoked potentials in infantile autism.

Biological Psychiatry

16(7), pp. 627-641

Read Abstract (New Window)

Martineau J. et al. (1989)

Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour.

Developmental Medicine and Child Neurology

31(6), pp. 721-727

Read Abstract (New Window)

Martineau J. , Barthélémy C. , LeLord G. (1986)

Long-term effects of combined vitamin B6-magnesium administration in an autistic child.

Biological Psychiatry

21(5), pp. 511-518

Martineau J. et al. (1985)

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

Biological Psychiatry

20(5), pp. 467-478

Read Abstract (New Window)

Menage P. et al. (1992)

CD4+ CD45RA+ T lymphocyte deficiency in autistic children: effect of a pyridoxine-magnesium treatment.

Brain Dysfunction

5(5), pp. 326-333

Vancassela S. et al. (2001)

Plasma fatty acid levels in autistic children.

Prostaglandins, Leukotrienes and Essential Fatty Acids

65(1), pp. 1-7.

Read Abstract (New Window)